Innovatus Life Sciences Acquisition Corp.

CIK: 1846550

SPAC Overview

$175M
IPO Size
Withdrawn
Current Status

Timeline Progress

About

Innovatus Life Sciences Acquisition Corp. is a blank-check company seeking a business combination, initially focused on identifying a prospective target in the life sciences sector. It has not selected a target.

Investment Focus

Healthcare

Geographic Focus

United States

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Underwriters

Extended Team Information

The team is led by David Schiff, Andrew Hobson and Claes Ekstrom, with independent director nominees Luis Diaz, Geoffrey Duyk and R. Erik Holmlin. Their backgrounds include investing and operating experience in life sciences, healthcare, biotechnology, finance and mergers and acquisitions; the sponsor is an affiliate of Innovatus Capital Partners, LLC.

Key Information

State of Incorporation
DE
SIC
6770
SPAC Ticker
N/A